These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunity to glycan α-Gal and possibilities for the control of COVID-19. la Fuente J; Gortázar C; Cabezas-Cruz A Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805 [No Abstract] [Full Text] [Related]
8. Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone. Larkin H JAMA; 2023 Feb; 329(7):531. PubMed ID: 36723971 [No Abstract] [Full Text] [Related]
9. The 49th Annual Meeting of the Japanese Society for Immunology: COVID-19 and Immunity. Shinkura R; Kang S; Arase H; Toyama-Sorimachi N Int Immunol; 2021 Mar; 33(4):193-196. PubMed ID: 33538811 [No Abstract] [Full Text] [Related]
11. Vaccines for SARS coronavirus 2 and the new normal in vaccinology. Griffiths PD Rev Med Virol; 2021 Mar; 31(2):e2229. PubMed ID: 33666285 [No Abstract] [Full Text] [Related]
12. Response to Mishra Krsak M; Harry BL; Palmer BE; Franco-Paredes C Viral Immunol; 2021 Nov; 34(9):659-660. PubMed ID: 34672802 [No Abstract] [Full Text] [Related]
13. [Not Available]. Meylan P Rev Med Suisse; 2020 Oct; 16(709):1895. PubMed ID: 33026736 [No Abstract] [Full Text] [Related]